Viewing StudyNCT03207009

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 10:15 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03207009
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2017-06-29
Brief Title: A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia
Sponsor: bluebird bio
Organization: bluebird bio
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Beta-Thalassemia
Keywords: